You are here:
PARGYLINE AND Y-BUTYROLACTONE ENHANCE TYROSINE HYDROXYLASE IMMUNOSTAINING OF NIGROSTRIATAL AXONS
Citation:
Coates, N., K. Jensen, J. Reinhard, AND P. O'Callaghan. PARGYLINE AND Y-BUTYROLACTONE ENHANCE TYROSINE HYDROXYLASE IMMUNOSTAINING OF NIGROSTRIATAL AXONS. U.S. Environmental Protection Agency, Washington, D.C., EPA/600/J-91/211 (NTIS PB91243022), 1991.
Description:
Administration of pargyline or q-butyrolactone enhanced immunostaining of tyrosine hydroxylase immunoreactive axons within the striatum. he qualitative characteristics of this enhancement were compound dependent and the enhancement was not associated with an increase in the amount tyrosine hydroxylase within the striatum. hese results indicate that immunostaining for neurotransmitter synthetic eyes can be pharmacologically enhanced without an increase in the synthesis of the enzyme.
URLs/Downloads:
PARGYLINE AND Y-BUTYROLACTONE ENHANCE TYROSINE HYDROXYLASE IMMUNOSTAINING OF NIGROSTRIATAL AXONSRecord Details:
Record Type:DOCUMENT( REPORT )
Product Published Date:12/31/1991
Record Last Revised:12/22/2005
Record ID:
31936